61655-72-9

Usage

Uses

Used in Pharmaceutical Synthesis:
2-Chloro-6-(dimethylamino)pyrazine is used as a building block for the development of new pharmaceuticals, leveraging its ability to undergo various chemical reactions to produce a wide range of valuable compounds.
Used in Agrochemical Synthesis:
In the agrochemical industry, 2-Chloro-6-(dimethylamino)pyrazine is utilized as a key intermediate, contributing to the creation of effective and innovative agrochemical products.
Used in Dye and Pigment Production:
2-Chloro-6-(dimethylamino)pyrazine is employed in the production of dyes and pigments, capitalizing on its chemical properties to create a diverse palette of colors for various applications.
Used as a Reagent in Organic Synthesis:
2-Chloro-6-(dimethylamino)pyrazine is used as a reagent in organic synthesis, facilitating a range of chemical reactions that are essential for the creation of complex organic molecules.
Used as a Precursor for Heterocyclic Compounds:
2-Chloro-6-(dimethylamino)pyrazine serves as a precursor in the preparation of heterocyclic compounds, which are important in various fields such as medicinal chemistry and materials science.
Used in the Development of New Materials:
2-Chloro-6-(dimethylamino)pyrazine has potential applications in the development of new materials, where its unique structure and reactivity can be harnessed to create innovative products with specific properties.

Upstream product

• 4774-14-5 2,6-dichloropyrazine 
• 506-59-2 N,N-dimethylammonium chloride 
• 124-40-3 dimethyl amine 

Downstream Products

• 136309-09-6 2-methoxy-6-dimethylaminopyrazine 

Relevant academic research and scientific papers

BIARYL DERIVATIVE AS GPR120 AGONIST

The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.

PIPERAZINOTRIZOLE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN DRUG PREPARATION

Provided is a piperazinotriazole compound represented by general formula I or an isomer, a pharmaceutically acceptable salt, ester, prodrug or hydrate thereof. Also provided are a method for preparing the compound, a drug composition containing the compou

MAP KINASE MODULATORS AND USES THEREOF

The invention provides for novel MAP kinase inhibitors and compositions comprising the same. In some embodiments, the MAP kinase inhibitors are p38a MAP kinase inhibitors. The invention further provides for methods for treatment of diseases comprising adm

N-pyrimidinyl-N-dialkylaminoalkyl ureas

Organic chemical compounds based upon the urea molecule are disclosed which have potent gastric secretion inhibitory properties. The urea is substituted with a 6 membered heterocyclic substituent containing 2 or 3 heteroatoms, and also with a substituted

Piperazinylpyrazines with central serotoninmimetic activity.

A series of 2-(1-piperazinyl)pyrazines was synthesized and evaluated for central serotonin-like activity. The most interesting member of the series, 6-chloro-2(1-piperazinyl)pyrazine (3a), had pharmacological properties characteristic of potent central serotoninmimetic activity and only weak peripheral serotoninmimetic action. Structural similarities between 3a and serotonin are discussed.